Teligent Cites Remediation-Related Activites For Poor Quarter
As Company Recalls Lidocaine Anesthetic Solution Due To Super Potency
New Jersey-based Teligent reported a low quarter as the company continues to focus on remediation measures to lift the FDA warning letter hanging over its Buena New Jersey manufacturing facilty. Teligent has also recently recalled a batch of its 4% lidocaine hydrochloride topical solution because the firm’s testing found it to be super potent.
